data

Arrowhead Pharmaceuticals Announces Interim Clinical Data on RNAi-based Obesity Candidates Showing Weight Loss in Obese Patients with Diabetes and Improved Measures of Body Composition

PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company’s investigational RNA interference (RNAi) therapeutics being developed…

Read more

Chronicle-TribuneSchools, local businesses partner to promote healthy living through DATA Quiz BowlStudents from around Grant County competed this week in the annual Grant County Drug, Alcohol and Tobacco Awareness (DATA) Quiz Bowl,….12 hours ago

Chronicle-TribuneSchools, local businesses partner to promote healthy living through DATA Quiz BowlStudents from around Grant County competed this week in the annual Grant County Drug, Alcohol and Tobacco Awareness (DATA)…

Read more